InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,346.56
(
-1.84%
)
US TECH 100
17,898.80
(
-2.65%
)
Dow Jones
39,737.26
(
-1.51%
)
Brent Oil
77.36
(
0.00%
)
Bitcoin
61,167.84
(
-0.41%
)
Post# of 252777
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iOwnSomeBio

Send PM Follow Ignore
Followers 4
Posts 1170
Boards Moderated 0
Alias Born 09/16/2005

iOwnSomeBio

Re: None

Tuesday, 07/07/2009 11:14:23 AM

Tuesday, July 07, 2009 11:14:23 AM

Post# of 252777
Sanofi Loses Bid To Stay Launch Of Generic Eloxatin
Law360, New York (July 06, 2009) -- A judge has denied Sanofi-Aventis US LLC's request to stay the launch of generic versions of its popular colon cancer drug Eloxatin pending appeal of a finding of noninfringement in Sanofi's suit against Sandoz Inc., Teva Pharmaceutical Industries Ltd. and others.

Judge Joel Pisano of the U.S. District Court for the District of New Jersey on Wednesday ruled that granting Sanofi's request would be “unwarranted.”...


http://ip.law360.com/registrations/user_registration?article_id=109601&concurrency_check=false

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up